By law, that list exists specifically for substances that aren't approved
Available from: Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al
Researchers at the University of Colorado Anschutz have published a proof-of-concept study in Fertility and Sterility demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS)
Some innovative formulations use encapsulation systems (liposomes, nanosomes) to improve the stability and transcutaneous penetration of GHK-Cu
Based on tirzepatide's experience, expect shortages for 12-24 months after retatrutide's commercial launch